Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Mol Psychiatry ; 22(1): 102-112, 2017 01.
Article in English | MEDLINE | ID: mdl-27021823

ABSTRACT

Prenatal exposure to infectious or inflammatory insults is increasingly recognized to contribute to the etiology of psychiatric disorders with neurodevelopmental components, including schizophrenia, autism and bipolar disorder. It remains unknown, however, if such immune-mediated brain anomalies can be transmitted to subsequent generations. Using an established mouse model of prenatal immune activation by the viral mimetic poly(I:C), we show that reduced sociability and increased cued fear expression are similarly present in the first- and second-generation offspring of immune-challenged ancestors. We further demonstrate that sensorimotor gating impairments are confined to the direct descendants of infected mothers, whereas increased behavioral despair emerges as a novel phenotype in the second generation. These transgenerational effects are mediated via the paternal lineage and are stable until the third generation, demonstrating transgenerational non-genetic inheritance of pathological traits following in-utero immune activation. Next-generation sequencing further demonstrated unique and overlapping genome-wide transcriptional changes in first- and second-generation offspring of immune-challenged ancestors. These transcriptional effects mirror the transgenerational effects on behavior, showing that prenatal immune activation leads to a transgenerational transmission (presence of similar phenotypes across generations) and modification (presence of distinct phenotypes across generations) of pathological traits. Together, our study demonstrates for, we believe, the first time that prenatal immune activation can negatively affect brain and behavioral functions in multiple generations. These findings thus highlight a novel pathological aspect of this early-life adversity in shaping disease risk across generations.


Subject(s)
Prenatal Exposure Delayed Effects/immunology , Prenatal Exposure Delayed Effects/pathology , Adaptive Immunity/immunology , Animals , Autistic Disorder/immunology , Autistic Disorder/pathology , Bipolar Disorder/immunology , Bipolar Disorder/pathology , Brain/pathology , Brain Diseases/immunology , Brain Diseases/pathology , Disease Models, Animal , Female , Infectious Disease Transmission, Vertical/veterinary , Male , Mice , Mice, Inbred C57BL , Pregnancy , Schizophrenia/immunology , Schizophrenia/pathology
2.
Mol Psychiatry ; 22(7): 961-971, 2017 07.
Article in English | MEDLINE | ID: mdl-27843148

ABSTRACT

Overconsumption of high-fat diets (HFDs) can critically affect synaptic and cognitive functions within telencephalic structures such as the medial prefrontal cortex (mPFC). The underlying mechanisms, however, remain largely unknown. Here we show that adolescence is a sensitive period for the emergence of prefrontal cognitive deficits in response to HFD. We establish that the synaptic modulator reelin (RELN) is a critical mediator of this vulnerability because (1) periadolescent HFD (pHFD) selectively downregulates prefrontal RELN+ cells and (2) augmenting mPFC RELN levels using transgenesis or prefrontal pharmacology prevents the pHFD-induced prefrontal cognitive deficits. We further identify N-methyl-d-aspartate-dependent long-term depression (NMDA-LTD) at prefrontal excitatory synapses as a synaptic signature of this association because pHFD abolishes NMDA-LTD, a function that is restored by RELN overexpression. We believe this study provides the first mechanistic insight into the vulnerability of the adolescent mPFC towards nutritional stress, such as HFDs. Our findings have primary relevance to obese individuals who are at an increased risk of developing neurological cognitive comorbidities, and may extend to multiple neuropsychiatric and neurological disorders in which RELN deficiency is a common feature.


Subject(s)
Cell Adhesion Molecules, Neuronal/metabolism , Extracellular Matrix Proteins/metabolism , Nerve Tissue Proteins/metabolism , Prefrontal Cortex/growth & development , Prefrontal Cortex/metabolism , Serine Endopeptidases/metabolism , Animals , Diet, High-Fat/adverse effects , Male , Malnutrition/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neuronal Plasticity , Receptors, N-Methyl-D-Aspartate/metabolism , Reelin Protein , Synapses/metabolism
3.
Transl Psychiatry ; 5: e637, 2015 Sep 15.
Article in English | MEDLINE | ID: mdl-26371765

ABSTRACT

Impairments in central reward processing constitute an important aspect of the negative symptoms of schizophrenia. Despite its clinical relevance, the etiology of deficient reward processing in schizophrenia remains largely unknown. Here, we used an epidemiologically informed mouse model of schizophrenia to explore the effects of prenatal immune activation on reward-related functions. The model is based on maternal administration of the viral mimic PolyI:C and has been developed in relation to the epidemiological evidence demonstrating enhanced risk of schizophrenia and related disorders following prenatal maternal infection. We show that prenatal immune activation induces selective deficits in the expression (but not acquisition) of conditioned place preference for a natural reward (sucrose) without changing hedonic or neophobic responses to the reward. On the other hand, prenatal immune activation led to enhanced place preference for the psychostimulant drug cocaine, while it attenuated the locomotor reaction to the drug. The prenatal exposure did not alter negative reinforcement learning as assessed using a contextual fear conditioning paradigm. Our findings suggest that the nature of reward-related abnormalities following prenatal immune challenge depends on the specificity of the reward (natural reward vs drug of abuse) as well as on the valence domain (positive vs negative reinforcement learning). Moreover, our data indicate that reward abnormalities emerging in prenatally immune-challenged offspring may, at least in part, stem from an inability to retrieve previously established context-reward associations and to integrate such information for appropriate goal-directed behavior.


Subject(s)
Neurodevelopmental Disorders/immunology , Neurodevelopmental Disorders/physiopathology , Prenatal Exposure Delayed Effects/immunology , Reward , Schizophrenia/immunology , Schizophrenia/physiopathology , Animals , Cocaine/immunology , Conditioning, Psychological/drug effects , Disease Models, Animal , Fear/drug effects , Fear/psychology , Female , Mice , Mice, Inbred C57BL , Neurodevelopmental Disorders/metabolism , Poly I-C/administration & dosage , Pregnancy , Prenatal Exposure Delayed Effects/metabolism , Prenatal Exposure Delayed Effects/physiopathology , Schizophrenia/metabolism , Sucrose/immunology
4.
J Neuroendocrinol ; 24(12): 1505-16, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22827554

ABSTRACT

Glucagon-like peptide-1 receptor (GLP-1R) agonists such as exendin-4 (Ex-4) affect eating and metabolism and are potential candidates for treating obesity and type II diabetes. In the present study, we tested whether vagal afferents mediate the eating-inhibitory and avoidance-inducing effects of Ex-4. Subdiaphragmatic vagal deafferentation (SDA) blunted the short-term (< 1 h) but not long-term eating-inhibitory effect of i.p.-infused Ex-4 (0.1 µg/kg) in rats. A dose of 1 µg/kg Ex-4 reduced 0.5, 1, 2 and 4 h cumulative food intake in SDA and sham-operated rats to a similar extent. Paradoxically, SDA but not sham rats developed a conditioned flavour avoidance (CFA) after i.p. Ex-4 (0.1 µg/kg). SDA completely blunted the induction of c-Fos expression by Ex-4 in the hypothalamic paraventricular nucleus. Ex-4, however, increased the number of c-Fos expressing cells, independent of intact vagal afferents, in the nucleus accumbens and in the central nucleus of the amygdala, the lateral external parabrachial nucleus, the caudal ventrolateral medulla and the dorsal vagal complex. These data suggest that intact vagal afferents are only necessary for the full expression of the early satiating effect of Ex-4 but not for later eating-inhibitory actions, when circulating Ex-4 might reach the brain via the circulation. Our data also dissociate the satiating and avoidance-inducing effects of the low Ex-4 dose tested under our conditions and suggest that vagal afferent signalling may protect against the development of CFA. Taken together, these findings reveal a complex role of vagal afferents in mediating the effects of GLP-1R activation on ingestive behaviour.


Subject(s)
Afferent Pathways/physiology , Avoidance Learning/drug effects , Peptides/pharmacology , Satiation/drug effects , Vagus Nerve/physiology , Venoms/pharmacology , Afferent Pathways/drug effects , Afferent Pathways/metabolism , Animals , Avoidance Learning/physiology , Brain/drug effects , Brain/metabolism , Brain/physiology , Drug Evaluation, Preclinical , Eating/drug effects , Exenatide , Feeding Behavior/drug effects , Feeding Behavior/physiology , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/pharmacology , Infusions, Parenteral , Male , Peptides/administration & dosage , Rats , Rats, Sprague-Dawley , Satiation/physiology , Taste/physiology , Vagus Nerve/drug effects , Vagus Nerve/metabolism , Venoms/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL